Bone loss in chronic inflammatory conditions

Journal of Musculoskeletal Neuronal Interactions

Volumn 3, Issue 4, 2003, Pages 287-289

  Goldring, Steven R ^a  

^a HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

Inflammation; Osteoclasts; Osteoporosis; Rank ligand; Rheumatoid arthritis

Indexed keywords

COLONY STIMULATING FACTOR 1; INTERLEUKIN 1; INTERLEUKIN 11; INTERLEUKIN 15; INTERLEUKIN 17; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PARATHYROID HORMONE; TUMOR NECROSIS FACTOR ALPHA;

ARTHRITIS; ARTICLE; BONE DISEASE; BONE REMODELING; CELL DIFFERENTIATION; CHRONIC INFLAMMATION; DISEASE ACTIVITY; GENETIC SUSCEPTIBILITY; HUMAN; IMMOBILIZATION; IMMUNOREGULATION; INFLAMMATORY CELL; JOINT DEGENERATION; JOINT FUNCTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOCLAST; OSTEOLYSIS; PATHOGENESIS; RHEUMATOID ARTHRITIS;

EID: 1642513681     PISSN: 11087161     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Goldring SR, Gravallese E. Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications. Arthritis Res 2000; 2:33-37.
2. Gravallese EM, Goldring SR. Cellular mechanisms and the role of cytokines in bone erosions in rheumatoid arthritis. Arthritis Rheum 2000; 43:2143-2151.
3. McGonagle D, Conaghan PG, O'Connor P, Gibbon W, Green M, Wakefield R, Ridgway J, Emery P. The relationship between synovitis and bone changes in early untreated rheumatoid arthritis; a controlled magnetic resonance imaging study. Arthritis Rheum 1999; 42:1706-1711.
4. Conaghan PG, O'Connor P, McGonagle D, Astin P, Wakefield RJ, Gibbon WW, Quinn M, Karim Z, Green MJ, Proudman S, Issacs J, Emery P. Elucidation of the relationship between synovitis and bone damage: a randomized magnetic resonance imaging study of individual patients with early rheumatoid arthritis. Arthritis Rheum 2003; 48:64-71.
5. Bromley M, Woolley DE. Histopathology of the rheumatoid lesion; identification of cell types at sites of cartilage erosion. Arthritis Rheum 1984; 27:857-863.
6. Gravallese EM, Harada Y, Wang JT, Gorn AH, Thornhill TS, Goldring SR. Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. Am J Pathol 1998; 152:943-951.
7. Haynes DR, Crotti TN, Loric M, Bain GI, Atkins GJ, Findlay DM. Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint. Rheumatology (Oxford) 2001; 40:623-630.
8. Leisen JCC, Duncan H, Riddle JM, Pitchford WC. The erosive front: a topographic study of the junction between the pannus and the subchondral plate in the macerated rheumatoid metacarpal head. J Rheumatol 1988; 15:17-22.
9. Kuratani T, Nagata K, Kukita T, Hotokebuchi T, Nakasima A, Iijima T. Induction of abundant osteoclast-like multinucleated giant cells in adjuvant arthritic rats with accompanying disordered high bone turnover. Histol Histopathol 1998; 13:751-759.
10. Romas E, Bakharevski O, Hards DK, Kartsogiannis V, Quinn JMW, Ryan PFJ, Martin J, Gillespie MT. Expression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritis. Arthritis Rheum 2000; 43:821-826.
11. Suzuki Y, Nishikaku F, Nakatuka M, Koga Y. Osteoclast-like cells in murine collagen induced arthritis. J Rheumatol 1998; 25:1154-1160.
12. Suzuki Y, Tsutsumi Y, Nakagawa M, Suzuki H, Matsushita K, Beppu M, Aoki H, Ichikawa Y, Mizushima Y. Osteoclast-like cells in an in vitro model of bone destruction by rheumatoid synovium. Rheumatology (Oxford) 2001; 40:673-682.
13. Chang JS, Quinn JM, Demaziere A, Bulstrode CJ, Francis MJ, Duthie RB, Athanasou NA. Bone resorption by cells isolated from rheumatoid synovium. Ann Rheum Dis 1992; 51:1223-1229.
14. Fujikawa Y, Shingu M, Torisu T, Itonaga I, Masumi S. Bone resorption by tartrate-resistant acid phosphatase-positive multinuclear cells isolated from rheumatoid synovium. Br J Rheumatol 1996; 35:213-217.
15. Pettit AR, Ji H, von Stechow D, Muller R, Goldring SR, Choi Y, Benoist C, Gravallese EM. TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. Am J Pathol 2001; 159:1689-1699.
16. Redlich K, Hayer S, Ricci R, David JP, Tohidast-Akrad M, Kollias G, Steiner G, Smolen J, Wagner EF, Schett G. Osteoclasts are essential for TNF-α -mediated joint destruction. J Clin Invest 2002; 110:1419-27.
17. Feldmann M, Brennan FM, Chantry D, Haworth C, Turner M, Abney E, Buchan G, Barrett K, Barkley D, Chu A, Field M. Cytokine production in the rheumatoid joint: implications for treatment. Ann Rheum Dis 1990; 49:480-486.
18. Funk JL, Cordaro LA, Wei H, Benjamin JB, Yocum DE. Synovium as a source of increased amino-terminal parathyroid hormone-related protein expression in rheumatoid arthritis; a possible role for locally produced parathyroid hormone-related protein in the pathogenesis of rheumatoid arthritis. J Clin Invest 1998; 101:1362-1371.
19. Chabaud M, Lubberts E, Joosten L, van Den Berg W, Miossec P. IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis. Arthritis Res 2001; 3:168-177.
20. Gravallese EM, Manning C, Tsay A, Naito A, Pan C, Amento E, Goldring SR. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum 2000; 43:250-258.
21. Horwood NJ, Kartsogiannis V, Quinn JMW, Romas E, Martin TJ, Gillespie MT. Activated T lymphocytes support osteoclast formation in vitro. Biochem Biophys Res Commun 1999; 265:144-150.
22. Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, Capparelli C, Li J, Elliott R, McCabe S, Wong T, Campagnuolo G, Moran E, Bogoch ER, Van G, Nguyen LT, Ohashi PS, Lacey DL, Fish E, Boyle WJ, Penninger JM. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 1999; 402:304-309.
23. Okano K, Tsukazaki T, Ohtsuru A, Namba H, Osaki M, Iwasaki K, Yamashita S. Parathyroid hormone-related peptide in synovial fluid and disease activity of rheumatoid arthritis. Br J Rheumatol 1996; 35:1056-1062.
24. Ogata Y, Kukita A, Kukita T, Komine M, Miyahara A, Miyazaki S, Kohashi O. A novel role of IL-15 in the development of osteoclasts: inability to replace its activity with IL-2. J Immunol 1999; 162:2754-2760.
25. Romas E, Gillespie M, Martin T. Involvement of receptor activator of NF-kb ligand and tumor necrosis factor-α in bone destruction in rheumatoid arthritis. Bone 2002; 30:340-346.
26. Romas E, Martin TJ. Cytokines in the pathogenesis of osteoporosis. Osteoporos Int 1997; 7:S47-S53.
27. Romas E, Sims N, Hards D, Lindsay M, Quinn J, Ryan P, Dunstan C, Martin T, Gillespie M. Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis. Am J Pathol 2002; 161:1419-1427.
28. Shimizu S, Shiozawa S, Shiozawa K, Imura S, Fujita T. Quantitative histologic studies on the pathogenesis of periarticular osteoporosis in rheumatoid arthritis. Arthritis Rheum 1985; 28:25-31.
29. Joffe I, Epstein S. Osteoporosis associated with rheumatoid arthritis: pathogenesis and management. Semin Arthritis Rheum 1991; 20:256-272.
30. Peel NF, Eastell R, Russell RGG. Osteoporosis in rheumatoid arthritis - the laboratory perspective. Br J Rheum 1991; 30:84-85.
31. Woolf AD. Osteoporosis in rheumatoid arthritis - the clinical viewpoint. Br J Rheum 1991; 30:82-84.
32. Saag K, Rochelle K, Caldwell J, Brasington R, Burmeister L, Zimmerman B, Kohler J, Furst D. Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events. Am J Med 1994; 96:115-123.
33. Spector TD, Hall GM, McCloskey EV, Kanis JA. Risk of vertebral fracture in women with rheumatoid arthritis. BMJ 1993; 306:558.
34. Verstraeten A, Dequeker J. Vertebral and peripheral bone mineral content and fracture incidence in postmenopausal patients with rheumatoid arthritis; effect of low-dose corticosteroids. Ann Rheum Dis 1986; 45:852-857.
35. Hooyman JR, Melton LJ, Nelson AM, O'Fallon WM, Riggs BL. Fractures after rheumatoid arthritis; a population based study. Arthritis Rheum 1984; 27:1353-1361.
36. Beat AM, Bloch DA, Fries JF. Predictors of fractures in early rheumatoid arthritis. J Rheumatol 1991; 18:804-808.
37. Compston JE, Vedi S, Croucher PI, Garrahan NJ, O'Sullivan MM. Bone turnover in non-steroid treated rheumatoid arthritis. Ann Rheum Dis 1994; 53:163-166.
38. Kroger H, Arnala I, Alhava EM. Bone remodeling in osteoporosis associated with rheumatoid arthritis. Calcif Tissue Int 1991; 49:S90.
39. Mellish RWE, O'Sullivan MM, Garrahan NJ, Compston JE. Iliac crest trabecular bone mass and structure in patients with non-steroid treated rheumatoid arthritis. Ann Rheum Dis 1987; 46:830-836.
40. Hall GM, Spector TD, Delmas PD. Markers of bone metabolism in postmenopausal women with rheumatoid arthritis. Effects of corticosteroids and hormone replacement therapy. Arthritis Rheum 1995; 38:902-906.
41. Gough AK, Peel NF, Eastell R, Holder RL, Lilley J, Emery P. Excretion of pyridinium crosslinks correlates with disease activity and appendicular bone loss in early rheumatoid arthritis. Ann Rheum Dis 1994; 53:14-17.
42. Gough A, Sambrook P, Devlin J, Huissoon A, Njeh C, Robbins S, Nguyen T, Emery P. Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis. J Rheumatol 1998; 7:1282-1289.
43. Iwamoto J, Takeda T, Ichimura S. Urinary cross-linked N-telopeptides of type I collagen levels in patients with rheumatoid arthritis. Calcif Tissue Int 2003; 72:491-497.
44. Garnero P, Landewe R, Boers M, Verhoeven A, Van Der Linden S, Christgau S, van der Heijde DM, Boonen A, Geusens P. Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study. Arthritis Rheum 2002; 46:2847-2856.
45. Gough AK, Lilley J, Eyre S, Holdin R, Emery P. Generalized bone loss in patients with rheumatoid arthritis. Lancet 1994; 344:23-27.